Chinook Therapeutics Inc.

NASDAQ: KDNY · Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM

Chinook Therapeutics Revenue Breakdown

Period Ending Dec 31, 2019 Dec 31, 2018
License And Service Revenue 17.26M 15.09M
License And Service Revenue Growth +14.39% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 12.99M 11.4M 9.77M 10.02M 8.63M 7.87M 7.74M 6.85M 7.77M 9.54M 11.02M 7.6M 3.88M 1.27M -21.7M 8.6M 7.98M 9.18M 9.15M 8.83M 9.04M 8.46M 8.24M 8.28M 8.56M 8.7M 9M 6.91M 5.88M 6.21M
Selling, General, and Administrative Revenue Growth +13.92% +16.78% -2.57% +16.07% +9.75% +1.64% +13.06% -11.86% -18.60% -13.43% +44.96% +96.03% +205.19% -105.86% -352.31% +7.78% -13.09% +0.36% +3.65% -2.41% +6.94% +2.58% -0.40% -3.25% -1.66% -3.32% +30.27% +17.44% -5.28% n/a
Research and Development Revenue 57.9M 50.88M 42.95M 41.98M 30.02M 26.25M 24.93M 23.57M 22.79M 25.7M 21.79M 9.23M 3.87M 2.82M -32.39M 15.25M 16.88M 19.53M 18.68M 19.42M 20.13M 24.45M 21.44M 20.57M 19.05M 26.88M 20.93M 11.81M 13.53M 10.65M
Research and Development Revenue Growth +13.78% +18.46% +2.31% +39.84% +14.36% +5.30% +5.76% +3.45% -11.32% +17.94% +136.01% +138.55% +37.33% -108.70% -312.39% -9.63% -13.59% +4.58% -3.84% -3.52% -17.69% +14.06% +4.22% +8.01% -29.15% +28.46% +77.15% -12.71% +27.12% n/a